Rx Bandz, LLC — Department of Defense SBIR Phase I: J201-CSO1
Rx Bandz, LLC — SBIR Phase I award from Department of Defense.
- Amount
- $49,887
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- J201-CSO1
- Solicitation
- 20.1
- NAICS
- —
- Place of performance
- TX
- Period
- 2020-03-09 → 2020-06-09
Description
The one-of-a-kind MiniJect™ can save lives of combatants at risk of chemical, biological, and radiological warfare. By delivering morphine, it can give severely injured warriors a better chance of survival. It reduces size and weight compared to similar devices, increases the mobility of the warrior, and improves the usefulness of the survival kit.